Copyright
©The Author(s) 2025.
World J Psychiatry. Sep 19, 2025; 15(9): 108910
Published online Sep 19, 2025. doi: 10.5498/wjp.v15.i9.108910
Published online Sep 19, 2025. doi: 10.5498/wjp.v15.i9.108910
Table 1 Core mild behavioral impairment domain and associated biomarkers
MBI behavioral domain | Typical symptoms | Peripheral blood biomarkers | Pathological mechanism | Ref. |
Impulse control disorder | Compulsive spending, aggressive speech | GFAP, NFL | Astrocyte activation → neuroinflammation → disruption of prefrontal inhibitory function | [9,16] |
Apathy | Reduced goal-directed behavior | YKL-40 | Blood-brain barrier disruption → central inflammation → dopaminergic pathway degeneration | [17,18] |
Emotional dysregulation | Depression, anxiety | P-tau181, P-tau217 | Tau protein pathology → neurotransmitter imbalance in limbic system | [19-21] |
Oxidative stress-related | Cognitive-behavioral vicious cycle | MDA, SOD | Free radical damage → neuronal dysfunction → exacerbation of neuroinflammation | [22] |
- Citation: Qiao WY, Guo QM, Li XH. Peripheral blood biomarkers and mild behavioral impairment in mild cognitive impairment: Clinical correlations and mechanistic insights. World J Psychiatry 2025; 15(9): 108910
- URL: https://www.wjgnet.com/2220-3206/full/v15/i9/108910.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i9.108910